AGP Executive Report
Last update: 6 hours agoAI in Pharma: A Swiss report highlights how AI is being used to speed up clinical trials, aiming to cut the decade-long, failure-prone drug-testing pipeline. Digital Medicine in Bern: The University of Bern and partners are using AI to analyse patient tissue samples, pushing faster, smarter research from lab to clinic. Cybersecurity/IoT: WISeKey filed key items for its 2026 AGM in Zurich, including board and auditor re-elections, as it continues to position itself in global cybersecurity and connected devices. Industrial Automation: ABB will supply Ethernet-APL automation for a major chemical plant in China, targeting higher-speed, real-time connectivity for more autonomous operations. AR/VR Displays: A market outlook session points to near-eye AR/VR progress, with waveguides and AI-driven glasses framed as the next growth battleground. Health Data Trend: A Swiss study finds colorectal cancer rising in adults under 50, with younger patients often diagnosed later—raising the stakes for awareness and screening. Travel Tech: Swiss eSIM providers are marketed as a way to avoid unpredictable roaming bills, letting travellers connect immediately on arrival. Regulatory/Markets: US prosecutors charged a Google engineer (Swiss resident) with insider trading tied to confidential search data used on Polymarket.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
